HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Lu Selected Research

Agammaglobulinaemia Tyrosine Kinase

11/2022Ibrutinib Prevents Acute Lung Injury via Multi-Targeting BTK, FLT3 and EGFR in Mice.
1/2021Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway.
1/2020Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Lu Research Topics

Disease

56Neoplasms (Cancer)
02/2024 - 01/2005
25Inflammation (Inflammations)
11/2023 - 01/2012
11Breast Neoplasms (Breast Cancer)
03/2023 - 01/2012
11Necrotizing Enterocolitis
01/2023 - 02/2014
10Infections
12/2021 - 12/2007
8Tuberculosis (Tuberculoses)
12/2024 - 01/2016
8Hepatocellular Carcinoma (Hepatoma)
12/2022 - 03/2006
6Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 09/2015
6Type 2 Diabetes Mellitus (MODY)
12/2023 - 04/2008
6Urinary Bladder Neoplasms (Bladder Cancer)
03/2023 - 01/2005
5Neoplasm Metastasis (Metastasis)
03/2024 - 11/2015
5Acute Lung Injury
03/2024 - 05/2015
5Ischemia
03/2024 - 01/2017
5Neuroinflammatory Diseases
03/2024 - 01/2021
5Pneumonia (Pneumonitis)
12/2023 - 12/2019
5Hypertension (High Blood Pressure)
10/2023 - 09/2015
5Hypoxia (Hypoxemia)
09/2023 - 09/2015
5Carcinogenesis
01/2023 - 01/2014
5Body Weight (Weight, Body)
01/2020 - 06/2015
4Fibrosis (Cirrhosis)
02/2024 - 09/2012
4Glaucoma
09/2023 - 01/2019
4COVID-19
01/2023 - 01/2022
4Brain Injuries (Brain Injury)
01/2023 - 11/2018
4Colonic Neoplasms (Colon Cancer)
01/2023 - 01/2012
4Lung Injury
03/2019 - 05/2015
4Colitis
01/2013 - 10/2011
4Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
12/2012 - 12/2007
3Cardiotoxicity
02/2024 - 01/2022
3Triple Negative Breast Neoplasms
02/2024 - 01/2019
3Hyperplasia
01/2024 - 11/2021
3Prostatic Neoplasms (Prostate Cancer)
12/2023 - 07/2007
3Hemorrhage
11/2023 - 12/2020
3Ocular Hypertension (Glaucoma, Suspect)
09/2023 - 01/2022
3Myocardial Ischemia (Ischemic Heart Diseases)
08/2023 - 01/2022
3Reperfusion Injury
03/2023 - 01/2022
3Wilms Tumor (Wilm's Tumor)
02/2023 - 01/2022
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 01/2019
3Atherosclerosis
01/2023 - 01/2018
3Cognitive Dysfunction
01/2023 - 12/2018
3Acute Kidney Injury (Acute Renal Failure)
01/2023 - 09/2019
3Liver Neoplasms (Liver Cancer)
12/2022 - 03/2006
3Idiopathic Pulmonary Fibrosis
05/2022 - 01/2021
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2019
3Leukemia
01/2022 - 11/2012
3Obesity
01/2021 - 01/2019
3Hereditary Angioedemas
01/2021 - 04/2020
3Weight Loss (Weight Reduction)
01/2021 - 06/2019
3B-Cell Lymphoma (Lymphoma, B Cell)
10/2020 - 01/2012
3Ischemic Stroke
05/2020 - 01/2013
3Asthma (Bronchial Asthma)
02/2020 - 01/2013
3Carcinoma (Carcinomatosis)
01/2020 - 07/2007
3Rheumatoid Arthritis
01/2017 - 01/2014
3Dengue (Dengue Fever)
01/2012 - 06/2008
2Necrosis
02/2024 - 03/2017
2Bacterial Infections (Bacterial Infection)
12/2023 - 12/2019

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2006
10MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
8Peptides (Polypeptides)IBA
03/2024 - 12/2007
7Messenger RNA (mRNA)IBA
03/2024 - 09/2012
7Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 02/2014
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2012
7Small Interfering RNA (siRNA)IBA
01/2019 - 07/2007
6Retinaldehyde (Retinal)IBA
03/2024 - 01/2020
6DNA (Deoxyribonucleic Acid)IBA
01/2023 - 04/2008
6Toll-Like Receptor 4IBA
01/2021 - 06/2015
5LipidsIBA
10/2023 - 01/2018
5Glucose (Dextrose)FDA LinkGeneric
10/2023 - 02/2017
5Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 01/2012
5Long Noncoding RNAIBA
03/2023 - 01/2019
5SolutionsIBA
01/2023 - 12/2007
5OligosaccharidesIBA
01/2023 - 10/2016
4Tuberculin (PPD)IBA
02/2023 - 01/2016
42'-fucosyllactoseIBA
01/2023 - 10/2016
4RNA (Ribonucleic Acid)IBA
01/2023 - 07/2007
4Therapeutic UsesIBA
12/2022 - 08/2014
4Drug CombinationsIBA
02/2016 - 01/2013
3Indicators and Reagents (Reagents)IBA
12/2023 - 01/2022
3Phosphotransferases (Kinase)IBA
03/2023 - 01/2019
3Interferon-gamma (Interferon, gamma)IBA
02/2023 - 01/2016
3MethyltransferasesIBA
01/2023 - 09/2015
3Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 11/2018
3ibrutinibIBA
01/2023 - 01/2021
3Agammaglobulinaemia Tyrosine KinaseIBA
11/2022 - 01/2020
3Air Pollutants (Pollutants, Air)IBA
07/2022 - 11/2019
3LipopolysaccharidesIBA
07/2022 - 12/2018
3CholesterolIBA
01/2022 - 01/2018
3Environmental Pollutants (Pollutants, Environmental)IBA
10/2020 - 01/2019
3Caspase 3 (Caspase-3)IBA
10/2020 - 01/2017
3tocilizumab (atlizumab)FDA Link
01/2017 - 01/2014
3Formaldehyde (Formol)FDA Link
12/2016 - 12/2007
3ElementsIBA
09/2015 - 04/2008
3hydroxide ionIBA
12/2012 - 12/2007
2ochratoxin AIBA
03/2024 - 10/2018
2ProdrugsIBA
12/2023 - 01/2005

Therapy/Procedure

23Therapeutics
02/2024 - 01/2012
10Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2023 - 01/2012
10Drug Therapy (Chemotherapy)
02/2023 - 01/2005
4Aftercare (After-Treatment)
01/2022 - 01/2005
3Renal Dialysis (Hemodialysis)
01/2024 - 11/2018
3Rejuvenation
01/2023 - 01/2021